Hyderabad, India, 2014 – Croissance Clinical Research, has chosen the Acceliant eClinial suite to aid clinical trial data management from Acceliant.
Acceliant’s, a global technology provider of innovation clinical trial management data solutions integrated e-PRO/EDC system offers a superior solution by allowing complete study data to be readily available and eliminating the integration costs.
Sri Manchala, CEO, Acceliant, commented, “Our integrated EDC-ePRO platform with innovative workflows and built-in mobility which allows data management from anywhere, anytime is designed to keep up with the ever-changing needs of the life sciences industry. Our collaboration with Croissance Clinical Research strengthens our clientele and helps us differentiate ourselves in this highly competitive marketplace.”
Satish Marukurthi, CEO, Croissance Clinical Research, commented “Acceliant is our partner of choice based on their proven track record of accomplishments and expertise. We evaluated Acceliant eClinical Suite as being superior to other products in terms of driving efficiency and accelerating clinical trial studies. I believe that leveraging on Acceliant’s knowledge and expertise will prove to be immensely beneficial for us in raising the standards of clinical trial efficiency. Keeping up with our accelerated growth in India, we are proud to partner with Acceliant. We look forward to a successful long-term relationship aiding them in clinical trial management. This partnership strengthens our commitment to provide unparalleled services in the space of clinical trial management solutions.”
Acceliantis the medical industry technology division of Trianz, a global technology services and solutions company. A pioneer in the EDC industry, Acceliant has been providing solutions in the clinical trial management space since 1999. The company caters to the needs of the pharmaceutical, biotechnology, medical device, CRO, and non-profit drug research industries. Acceliant has helped facilitate clinical data management in hundreds of trials worldwide encompassing dozens of therapeutic areas for global giants as well as emerging healthcare innovators.